Sodium bicarbonate reduces incidence of contrast-induced nephropathy
May 13, 2009A meta-analysis of 17 randomised controlled trials has shown that pre-procedural treatment with sodium bicarbonate based hydration is the optimal treatment strategy to prevent contrast-induced nephropathy (CIN). The research, published in the open access journal BMC Medicine, shows that although the benefit may have been overestimated by previous studies, sodium bicarbonate is clearly superior to normal saline.
Hitinder Gurm from the University of Michigan worked with a team of international researchers to study the results of trials featuring a total of 2633 people to assess the effectiveness of saline versus sodium bicarbonate for the prevention of CIN. According to Gurm, "Contrast agents are administered in millions of procedures annually worldwide. In the USA and Europe, contrast-induced nephropathy (CIN) is the third leading cause of acute renal failure in hospitalized patients, accounting for about 10% of hospital-acquired renal failure. Although CIN is generally limited to a transient decline of renal function, it cannot be regarded as a benign complication - as many as 30% of cases result in lasting kidney damage".
The authors found that CIN occurred in 109 of the 1327 patients treated with sodium bicarbonate and in 175 of the 1306 patients who received normal saline. The number needed to prevent one case of CIN was 16. The exact mechanism of CIN is still unknown, but sodium bicarbonate is thought to prevent it by increasing the alkalinity of tubular fluid and thereby limiting free radical production. Gurm said, "Six studies monitored the degree of alkalinization and all but one found a significant increase. Interestingly this one study did not find a benefit of sodium bicarbonate. Therefore, it could be hypothesized that the bicarbonate should be dosed to achieve urinary alkalinization".
More information: Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis
Pascal Meier, Dennis T Ko, Akira Tamura, Umesh Tamhane and Hitinder S Gurm
BMC Medicine (in press), http://www.biomedc … .com/bmcmed/
-
Scientists identify blood component that turns bacteria virulent
Nov 21, 2008 |
not rated yet |
0
-
Kidney damage caused by iodinated contrast material thought to be overestimated, study shows
Jul 16, 2008 |
not rated yet |
0
-
Calcium and vitamin D may not be the only protection against bone loss
Dec 03, 2008 |
not rated yet |
0
-
Research ties harmless viruses to cancer
Feb 22, 2007 |
not rated yet |
0
-
Low-sodium advice for asthmatics should be taken with a grain of salt
Jul 15, 2008 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Team isolates nerve cells involved in storing long term memory and gene proteins associated with them
(Medical Xpress) -- A research team in Taiwan has succeeded in isolating two nerve cells in fruit fly brains that are believed to be the major players in allowing for the formation of long term memories. Furthermore, ...
News of plaque-clearing drug tops week of major advances against Alzheimer's disease
In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease. At the same time, the White House and members of Congress are proposing increases in Alzheimer's research ...
51 minutes ago |
not rated yet |
1
To avoid early labor and delivery, weight and diet changes not the answer
One of the strongest known risk factors for spontaneous or unexpected preterm birth any birth that occurs before the 37th week of pregnancy, most often without a known cause is already having had one. For women ...
4 minutes ago |
not rated yet |
0
|
Joint patent for using the BRCA1 gene as a therapy for cardiovascular disease
St. Michael's Hospital and King Saud University have received their first joint U.S. patent to use the BRCA1 gene as a therapy for cardiovascular disease.
20 minutes ago |
not rated yet |
0
S.Africa in $208 mln AIDS drug venture with Swiss Lonza
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.
Medicine & Health / HIV & AIDS
1 hour ago |
not rated yet |
0
The power of estrogen -- male snakes attract other males
A new study has shown that boosting the estrogen levels of male garter snakes causes them to secrete the same pheromones that females use to attract suitors, and turned the males into just about the sexiest ...
Could Venus be shifting gear?
(PhysOrg.com) -- ESAs Venus Express spacecraft has discovered that our cloud-covered neighbour spins a little slower than previously measured. Peering through the dense atmosphere in the infrared, the ...
Experts reveal how plants don't get sunburn
(PhysOrg.com) -- Experts at the University of Glasgow have discovered how plants survive the harmful rays of the sun.
Fool's gold may prove an unlikely alternative to overexploited catalytic materials
Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...
SLAC, Stanford team focuses on high-energy electrons to treat cancer
Accelerator physicists at SLAC and cancer specialists from Stanford are working on a new technology that could dramatically reduce the time needed for cancer radiation treatments. The team ran an initial experiment ...
Unpicking HIV’s invisibility cloak
Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel targetits camouflage coat. HIV hides inside a cloak unusually rich in a sugar ...